Highlights

• Titomic (ASX:TTT) shares traded lower as investors continue monitoring the company’s commercialisation progress.
• The company is focused on expanding its cold spray Manufacturing opportunities in the US defence and space sectors.
• Titomic has secured development agreements and technical validation milestones supporting its technology pathway.
• Key focus areas include contract conversion, Revenue growth and progress across US operations.

Titomic (ASX:TTT) remains focused on advancing its cold spray additive manufacturing technology into commercial applications, with particular attention on the US defence and space markets. The company’s shares were trading at AUD 0.17,…